CCRM

Commercializing Living Therapies with CCRM

Science EN ↓ Epizody: 28

Hear from academic and industry experts sharing insider insights, information and trend forecasts for the cell and gene therapy industry. “Commercializing Living Therapies with CCRM” is brought to you by CCRM, a leader in developing, manufacturing and commercializing regenerative medicine-based technologies, and cell and gene therapies. Questions / comments? email: podcast@ccrm.ca.

Určitě navštivte web podcastu a podpořte jeho tvůrce: www.ccrm.ca

Autor

CCRM

Kategorie

Science

Web podcastu

www.ccrm.ca

Nejnovější epizoda

15. říj 2026

Kde poslouchat?

Podcasty v aplikaci Replaio Radio Už brzy

Podcasty míří do aplikace už brzy. Nainstaluj si ji teď a jako první uvidíš úplně nový pohled na podcasty

Stáhnout z Google Play Nainstaluj zdarma Android 10 mil.+ stažení · hodnocení 4,7+ iOS už brzy

Epizody

Moving from A to B 14.02.2022

Manufacturing and supply chain issues in cell and gene therapies.    Featuring:  Dr. Anthony Davies, Founder and CEO, Dark Horse Consulting  Rob Jones, Vice President, Global Bioservices, Cryoport Systems   It’s no secret that supply chain and manufacturing are crucial to the cell and gene therapy industry, but now the whole world seems to be paying attention. This sudden interest has made Anthony...

Chaperoning innovation through the valley of death 14.01.2022

The business of regenerative medicine and investment.   Featuring:  Dr. Cynthia Lavoie, President and Chief Investment Officer, CCRM Enterprises  Geoff MacKay, President and CEO, AVROBIO  Dr. Lavoie and Mr. MacKay share what brought them to regenerative medicine in the first place, why investors are bullish about the field, and which trends they have an eye on as they are looking to the future. Jo...

The importance of educating the public about cell and gene therapies 14.12.2021

How can the regenerative medicine community create broader societal awareness?  Featuring:  Dr. Janet Rossant, President and Scientific Director, Gairdner Foundation Dr. Phil Vanek, Chief Technology Officer, Gamma Biosciences Drs. Rossant and Vanek discuss public awareness of cell and gene therapies, the importance of improving it, and how confusing and misleading claims made about unapproved stem...

Poslouchej podcast Commercializing Living Therapies with CCRM v Replaio

Rádio a podcasty v jedné aplikaci - zdarma a bez registrace. Nainstaluj si ji ještě dnes a nepropásni premiéru

Stáhnout z Google Play

Replaio není vydavatelem podcastů; názvy pořadů, obálky a audio patří jejich autorům a šíří se přes veřejné RSS kanály